Zilganersen
Zilganersen (ION373) is a glial fibrillary acidic protein (GFAP) inhibitor, an antisense oligonucleotide. Zilganersen can be used in Alexander disease (AxD) research[1][2].
Product Specifications
CAS Number
2305355-56-8
Product Name Alternative
ION373
UNSPSC
12352208
Target
FAP
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/zilganersen.html
Purity
91.43
Solubility
10 mM in DMSO
Smiles
[Zilganersen]
Molecular Formula
C230H320N67O127P19S
Molecular Weight
7060.80
References & Citations
[1]Helm J, et al. Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases. Pharmaceutics. 2022 Aug 16;14 (8) :1708.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
M2360-02S-AP 100 µL
MAP Kinase 3 (Mitogen-activated Protein Kinase 3, MAPK 3, Mapk3, ERT2, Extracellular Signal-regulated Kinase 1, ERK1, ERK-1, Esrk1, Insulin-stimulated MAP2 Kinase, MAP Kinase Isoform p44, Microtubule-associated Protein 2 Kinase, Mitogen-activated Protein Kinase 1, MAP Kinase 1, MAPK 1, MAPK1, MNK1, p44, p44erk1, p44-ERK1, p44mapk, p44-MAPK, Prkm3) (AP) discontinued
Sign In for Pricing
View Details 